Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease

http://theroc.us/researchlibrary/Targeting%20CB2%20cannabinoid%20receptors%20as%20a%20novel%20therapy%20to%20treat%20malignant%20lymphoblastic%20disease.pdf